Design of a true bivalent ligand with picomolar affinity for a G protein-coupled receptor homodimer

Bivalent ligands have emerged as chemical tools to study G protein-coupled receptor dimers. Using a combination of computational, chemical, and biochemical tools, here we describe the design of bivalent ligand 13 with high affinity (KDB1=21 pM) for the dopa-mine D2 receptor (D2R) homodimer. Bivalent...

Descripción completa

Detalles Bibliográficos
Autores: Pulido, Daniel, Casadó Anguera, Verònica, Pérez-Benito, Laura, Moreno Guillén, Estefanía, Cordomí, Arnau, López, Laura, Cortés Tejedor, Antonio, Ferré, Sergi, Pardo, Leonardo, Casadó, Vicent, Royo Expósito, Miriam
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2018
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/226043
Acceso en línea:https://hdl.handle.net/2445/226043
Access Level:acceso abierto
Palabra clave:Receptors cel·lulars
Proteïnes G
Cell receptors
G Proteins
Descripción
Sumario:Bivalent ligands have emerged as chemical tools to study G protein-coupled receptor dimers. Using a combination of computational, chemical, and biochemical tools, here we describe the design of bivalent ligand 13 with high affinity (KDB1=21 pM) for the dopa-mine D2 receptor (D2R) homodimer. Bivalent ligand 13 enhances the binding affinity relative to monovalent compound 15 by 37-fold, indicating simultaneous binding at both protomers. Using synthetic peptides with amino acid sequences of transmembrane (TM) domains of D2R, we provide evidence that TM6 forms the interface of the homodimer. Notably, the disturber peptide TAT-TM6 decreased the binding of bivalent ligand 13 by 52-fold and had no effect on monovalent compound 15, confirming the D2R homodimer through TM6 ex-vivo. In conclusion, using a versatile multivalent chemical platform, we have developed a precise strategy to generate a true bivalent ligand that simultaneously targets both orthosteric sites of the D2R homodimer